Fig. 43.9
Hospitalization for HF in the WASH and WATCH trials. In WASH, there were 41% fewer patients (p = 0.032) and 31% fewer events in the warfarin group compared with aspirin, and in WATCH, 27% fewer patients (p = 0.01) and 31% fewer events.8,9
Hospitalization for HF in the WASH and WATCH trials. In WASH, there were 41% fewer patients (p = 0.032) and 31% fewer events in the warfarin group compared with aspirin, and in WATCH, 27% fewer patients (p = 0.01) and 31% fewer events.8,9
